All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. [Antibiotics use in hospitals for acute pyelonephritis]

    KCE Reports 3 (2004)

    https://kce.fgov.be/en/publication/report/antibiotics-use-in-hospitals-for-acute-pyelonephritis

  2. [Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium]

    KCE Reports 157 (2011)

    https://kce.fgov.be/en/publication/report/economic-evaluation-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium

  3. [Effectiveness and cost-effectiveness of treatments for smoking cessation]

    KCE Reports 1 (2004) 22 juillet 2004 (1st print), août 2005 (2nd print)

    https://kce.fgov.be/en/publication/report/effectiveness-and-cost-effectiveness-of-treatments-for-smoking-cessation

  4. [Financing of hospital drugs: a descriptive study of several European countries and Canada]

    KCE Reports 8 (2005)

    https://kce.fgov.be/en/publication/report/financing-of-hospital-drugs-a-descriptive-study-of-several-european-countries-and

  5. [Statins in Belgium: utilization trends and impact of reimbursement policies]

    KCE Reports 141 (2010)

    https://kce.fgov.be/en/publication/report/statins-in-belgium-utilization-trends-and-impact-of-reimbursement-policies

  6. [Vaccine safety surveillance in Belgium : place and limits of a background rate approach]

    KCE Reports 188 (2012)

    https://kce.fgov.be/en/publication/report/vaccine-safety-surveillance-in-belgium-place-and-limits-of-a-background-rate-appr

  7. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/publication/report/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effective

  8. Antiviral agents in seasonal and pandemic influenza. Literature study and development of practice guidelines

    KCE Reports 49 (2006)

    https://kce.fgov.be/en/publication/report/antiviral-agents-in-seasonal-and-pandemic-influenza-literature-study-and-developm

  9. Barriers and opportunities for the uptake of biosimilar medicines in Belgium

    KCE Reports 199 (2013)

    https://kce.fgov.be/en/publication/report/barriers-and-opportunities-for-the-uptake-of-biosimilar-medicines-in-belgium
  10. Children in a playground

    Cost-effectiveness analysis of HPV vaccination of boys in Belgium

    KCE Reports 308 (2019) The vaccine for the human papilloma virus (HPV) which causes cervical cancer was introduced about ten years ago in Belgium, but only girls benefit from it. However, it is now established that this same virus is also involved in other cancers, including throat cancer. The recommendations have thus been reviewed and here, as in most western countries, it is now recommended to vaccinate boys too.

    https://kce.fgov.be/en/cost-effectiveness-analysis-of-hpv-vaccination-of-boys-in-belgium

  11. Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study

    KCE Reports 127 (2010)

    https://kce.fgov.be/en/publication/report/cost-effectiveness-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium-part-

  12. Drug reimbursement systems: international comparison and policy recommendations

    KCE Reports 147 (2010)

    https://kce.fgov.be/en/publication/report/drug-reimbursement-systems-international-comparison-and-policy-recommendations-0

  13. Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C

    KCE Reports 276 (2016)

    https://kce.fgov.be/en/publication/report/economic-evaluation-of-novel-direct-acting-antiviral-daa-treatment-strategies-for

  14. Future scenarios about drug development and drug pricing

    KCE Reports 271 (2016)

    https://kce.fgov.be/en/publication/report/future-scenarios-about-drug-development-and-drug-pricing
  15. Pils

    Guideline on the prudent prescription of antibiotics in the dental office

    KCE Reports R332C

    https://kce.fgov.be/en/guideline-on-the-prudent-prescription-of-antibiotics-in-the-dental-office

  16. Medication use in rest and nursing homes in Belgium.

    KCE Reports 47 (2006)

    https://kce.fgov.be/en/publication/report/medication-use-in-rest-and-nursing-homes-in-belgium

  17. Pharmaceutical and non-pharmaceutical interventions for Alzheimer’s Disease, a rapid assessment

    KCE Reports 111 (2009)

    https://kce.fgov.be/en/publication/report/pharmaceutical-and-non-pharmaceutical-interventions-for-alzheimer%E2%80%99s-disease-a-rap

  18. Pharmacological and surgical treatment of obesity. Residential care for severely obese children in Belgium.

    KCE Reports 36 (2006) August 2006 (3rd edition ; 2nd edition : July 2006 ; 1st edition : June 2006)

    https://kce.fgov.be/en/publication/report/pharmacological-and-surgical-treatment-of-obesity-residential-care-for-severely-o

  19. Pharmacological prevention of fragility fractures in Belgium

    KCE Reports 159 (2011)

    https://kce.fgov.be/en/publication/report/pharmacological-prevention-of-fragility-fractures-in-belgium

  20. Policies for Rare Diseases and Orphan Drugs

    KCE Reports 112 (2009)

    https://kce.fgov.be/en/publication/report/policies-for-rare-diseases-and-orphan-drugs

Pages